Bayer Pharmaceuticals Corporation; Onyx Pharmaceuticals, Inc.

Bayer and Onyx Announce European Marketing Submission for Sorafenib

West Haven, Connecticut, and Emeryville, California (ots/PRNewswire) - - European Trial to Provide Access to Sorafenib for Individuals with Advanced Renal Cell Carcinoma Bayer Pharmaceuticals Corporation (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that a Marketing Authorization Application (MAA) has been submitted by Bayer to the European Medicines Agency (EMEA) in London for the ...